DANIEL PENNY to Sulfonamides
This is a "connection" page, showing publications DANIEL PENNY has written about Sulfonamides.
Connection Strength
0.776
-
Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL Trial. J Am Heart Assoc. 2025 Aug 19; 14(16):e041348.
Score: 0.206
-
The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis. Pediatr Cardiol. 2023 Dec; 44(8):1691-1701.
Score: 0.178
-
Results of the FUEL Trial. Circulation. 2020 02 25; 141(8):641-651.
Score: 0.138
-
Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial. Am Heart J. 2018 07; 201:1-8.
Score: 0.124
-
Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension. J Heart Lung Transplant. 2006 Apr; 25(4):469-73.
Score: 0.054
-
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation. J Am Heart Assoc. 2025 Apr; 14(7):e038061.
Score: 0.050
-
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report. BMC Pulm Med. 2016 Jan 22; 16:17.
Score: 0.027